Lenvatinib versus placebo in radioiodine-refractory thyroid cancer

Martin Schlumberger, Makoto Tahara, Lori J. Wirth, Bruce Robinson, Marcia S. Brose, Rossella Elisei, Mouhammed Amir Habra, Kate Newbold, Manisha H. Shah, Ana O. Hoff, Andrew G. Gianoukakis, Naomi Kiyota, Matthew H. Taylor, Sung Bae Kim, Monika K. Krzyzanowska, Corina E. Dutcus, Begoña De Las Heras, Junming Zhu, Steven I. Sherman

Research output: Contribution to journalArticlepeer-review

959 Scopus citations

Fingerprint

Dive into the research topics of 'Lenvatinib versus placebo in radioiodine-refractory thyroid cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences